Recurrent disease in juvenile differentiated thyroid carcinoma: Prognostic factors, treatments, and outcomes

Journal of Nuclear Medicine

Volumn 55, Issue 5, 2014, Pages 710-717

  Mihailovic, Jasna ^a,b   Nikoletic, Katarina ^a   Srbovan, Dolores ^a  

^a ONCOLOGY INSTITUTE OF VOJVODINA   (Serbia)

^b UNIVERSITY OF NOVI SAD   (Serbia)

Author keywords

Differentiated thyroid carcinoma; Juvenile; Outcome; Radioiodine therapy; Recurrence

Indexed keywords

IODINE 131;

AGE; ARTICLE; CANCER MORTALITY; CANCER PROGNOSIS; CANCER RECURRENCE; CANCER REGRESSION; CANCER STAGING; CANCER SURVIVAL; CANCER THERAPY; CAUSE OF DEATH; CONTROLLED STUDY; DIFFERENTIATED THYROID CANCER; DISTANT METASTASIS; FEMALE; HISTOPATHOLOGY; HUMAN; JUVENILE DIFFERENTIATED THYROID CANCER; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; SUBTOTAL THYROIDECTOMY; SURVIVAL RATE;

DIFFERENTIATED THYROID CARCINOMA; JUVENILE; OUTCOME; RADIOIODINE THERAPY; RECURRENCE;

ADOLESCENT; CARCINOMA; CHILD; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HUMANS; IODINE RADIOISOTOPES; MALE; NEOPLASM METASTASIS; NEOPLASM RECURRENCE, LOCAL; PROBABILITY; PROGNOSIS; REMISSION INDUCTION; RETROSPECTIVE STUDIES; THYROID NEOPLASMS; THYROIDECTOMY; TIME FACTORS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84901360147     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: 10.2967/jnumed.113.130450     Document Type: Article

References (38)

1. Hung W, Sarlis NJ. Current controversies in the management of pediatric patients with well-differentiated nonmedullary thyroid cancer: a review. Thyroid. 2002;12:683-702.
2. Ries LAG, Melbert D, Krapcho M, et al., eds. SEER Cancer Statistics Review, 1975-2004. Bethesda, MD: National Cancer Institute; 2007.
3. Cancer incidence and mortality in central Serbia, 1999-2010. Institute of Public Health of Serbia website. Available by searching for the specific year of the report at: http://www.batut.org.rs/index.php. Accessed March 28, 2014.
4. Cancer registry data of Oncology Institute of Vojvodina [unpublished database]. Sremska Kamenica, Serbia: Oncology Institute of Vojvodina; 2010.
5. Giuffrida D, Scollo C, Pellegriti G, et al. Differentiated thyroid cancer in children and adolescents. J Endocrinol Invest. 2002;25:18-24.
6. Zimmerman D, Hay ID, Gough IR, et al. Papillary thyroid carcinoma in children and adults: long-term follow-up of 1039 patients conservatively treated at one institution during three decades. Surgery. 1988;104:1157-1166.
7. Brink JS, van Heerden JA, McIver B, et al. Papillary thyroid cancer with pulmonary metastases in children: long term prognosis. Surgery. 2000;128:881-886.
8. Hogan AR, Zhuge Y, Perez EA, et al. Pediatric thyroid carcinoma: incidence and outcome in 1753 patients. J Surg Res. 2009;156:167-172.
9. Newman KD, Black T, Heller G, et al. Differentiated thyroid cancer: determinants of disease progression in patients, 21 years of age at diagnosis: a report from the Surgical Discipline Committee of the Children's Cancer Group. Ann Surg. 1998;227:533-541.
10. Welch Dinauer CA, Tuttle RM, Robie DK, et al. Clinical features associated with metastasis and recurrence of differentiated thyroid cancer in children, adolescents and young adults. Clin Endocrinol (Oxf). 1998;49:619-628.
11. Grigsby PW, Gal-or A, Michalsky JM, et al. Childhood adolescent thyroid carcinoma. Cancer. 2002;95:724-729.
12. Hay ID, Gonzalez-Losada T, Reinalda MS, et al. Long-term outcome in 215 children and adolescents with papillary thyroid cancer treated during 1940 through 2008. World J Surg. 2010;34:1192-1202.
13. Sobin LH, Gospodarowicz MK, Wittekind C, eds. TNM Classification of Malignant Tumours. 7th ed. West Sussex, England: Wiley-Blackwell Publishing; 2010:58-62.
14. Bernstein L, Gurney JG. Carcinomas and other malignant epithelial neoplasms: ICCC XI. In: Ries LAG, Smith MA, Gurney JG, et al., eds. Cancer Incidence and Survival Among Children and Adolescents: United States SEER Program 1975-1995. Bethesda, MD: National Cancer Institute; 1999:139-147. Publication 99-4649.
15. Huang CH, Chao TC, Hseuh C, et al. Therapeutic outcome and prognosis in young patients with papillary and follicular thyroid cancer. Pediatr Surg Int. 2012;28:489-494.
16. Enomoto Y, Enomoto E, Uchino S, et al. Clinical features, treatment, and longterm outcome of papillary thyroid cancer in children and adolescents without radiation exposure. World J Surg. 2012;36:1241-1246.
17. Papendieck P, Grunero-Papendieck L, Venara M, et al. Differentiated thyroid carcinoma: presentation and follow-up in children and adolescents. J Pediatr Endocrinol Metab. 2011;24:743-748.
18. Popovtzer A, Shpitzer T, Bahar G, Feinmesser R, Segal K. Thyroid cancer in children: management and outcome experience of a referral center. Otolaryngol Head Neck Surg. 2006;135:581-584.
19. Handkiewicz-Junak D, Wloch J, Roskosz J, et al. Total thyroidectomy and adjuvant radioiodine treatment independently decrease locoregional recurrence risk in childhood and adolescent differentiated thyroid cancer. J Nucl Med. 2007;48: 879-888.
20. Demidchik YE, Demidchik EP, Reiners C, et al. Comprehensive clinical assessment of 740 cases of surgically treated thyroid cancer in children of Belarus. Ann Surg. 2006;243:525-532.
21. Lazar L, Lebenthal Y, Steinmetz A, Yackobovitch-Gavan M, Phillip M. Differentiated thyroid carcinoma in pediatric patients: comparison of presentation and course between pre-pubertal children and adolescents. J Pediatr. 2009;154:708-714.
22. Dardas M, Abboud M, Salti I, et al. Thyroid cancer in Lebanese children and adolescents: a 15-year experience at a single institution. Pediatr Hematol Oncol. 2009;26:439-447.
23. Landau D, Vini L, A'Hern R, Harmer C. Thyroid cancer in children: the Royal Marsden Hospital experience. Eur J Cancer. 2000;36:214-220.
24. Alessandri AJ, Goddard KJ, Blair GK, et al. Age is the major determinant of recurrence in pediatric differentiated thyroid carcinoma. Med Pediatr Oncol. 2000;35:41-46.
25. Farahati J, Bucsky P, Parlowsky T, Mader U, Reiners C. Characteristics of differentiated thyroid carcinoma in children and adolescents with respect to age, gender, and histology. Cancer. 1997;80:2156-2162.
26. LaQuardia MP, Corbally MT, Heller G, et al. Recurrence and morbidity in differentiated thyroid cancer in children. Surgery. 1998;104:1149-1156.
27. Jarzab B, Handkiewicz Junak D, Wloch J, et al. Multivariate analysis of prognostic factors for differentiated thyroid carcinoma in children. Eur J Nucl Med. 2000;27:833-841.
28. Palmer BA, Zarroug AE, Poley RN, Kollars JP, Moir CR. Papillary thyroid carcinoma in children: risk factors and complications of disease recurrence. J Pediatr Surg. 2005;40:1284-1288.
29. Spinelli C, Bertocchini A, Antonelli A, Miccoli P. Surgical therapy of the thyroid papillary carcinoma in children: experience with 56 patients #16 years old. J Pediatr Surg. 2004;39:1500-1505.
30. Borson-Chazot F, Causeret S, Lifante JC, Augros M, Berger N, Peix JL. Predictive factors for recurrence from a series of 74 children and adolescents with differentiated thyroid cancer. World J Surg. 2004;28:1088-1092.
31. Lin JD, Chao TC, Hsueh C, Kuo SF. High recurrent rate of multicentric papillary thyroid carcinoma. Ann Surg Oncol. 2009;16:2609-2616.
32. Wada N, Sugino K, Mimura T, et al. Pediatric differentiated thyroid carcinoma in stage I: risk factor analysis for disease free survival. BMC Cancer. 2009;9:306.
33. Bargren AE, Meyer-Rochow GY, Delbridge LW, Sidhu SB, Chen H. Outcomes of surgically managed pediatric thyroid cancer. J Surg Res. 2009;156:70-73.
34. La Quaglia MP, Black T, Holcomb GW, et al. Differentiated cancer: clinical characteristics, treatment, and outcome in patients under 21 years of age who present with distant metastases-a report from the Surgical Discipline Committee of the Children's Cancer Group. J Pediatr Surg. 2000;35:955-959.
35. O'Gorman CS, Hamilton J, Rachmiel M, et al. Thyroid cancer in childhood: a retrospective review of childhood course. Thyroid. 2010;20:375-380.
36. Beasley NJ, Lee J, Eski S, et al. Impact of nodal metastases on prognosis in patients with well differentiated thyroid cancer. Arch Otolaryngol Head Neck Surg. 2002;128:825-828.
37. Leboulleux S, Baudin E, Hartl DW, Travagli JP, Schlumberger M. Follicular cellderived thyroid cancer in children. Horm Res. 2005;63:145-151.
38. Chow SM, Law SCK, Mendenhall WM, Au SK, Yau S, Lau WH. Differentiated thyroid carcinoma in childhood and adolescence: clinical course and role of radioiodine. Pediatr Blood Cancer. 2004;42:176-183.